Updated Jul 16, 2026
Mock James M has filed 4 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $104K.
James M. Mock is the Chief Financial Officer of Moderna, Inc., a leading biotech company known for its mRNA technology and COVID-19 vaccine. He has been involved in the financial operations of the company, contributing to its growth and development in the biotech sector.
| Role | Chief Financial Officer |
|---|---|
| Notability | 50/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-06 | MRNA | Moderna, Inc. | F — Tax withholding / forfeiture | 703 | $72.50 | $51K |
| 2026-07-06 | MRNA | Moderna, Inc. | M — Option exercise | 1.5K | — | |
| 2026-06-08 | MRNA | Moderna, Inc. | F — Tax withholding / forfeiture | 5.7K | $51.59 | $294K |
| 2026-06-08 | MRNA | Moderna, Inc. | M — Option exercise | 11.8K | — | |
| 2026-06-03 | MRNA | Moderna, Inc. | F — Tax withholding / forfeiture | 1.2K | $47.19 | $56K |
| 2026-06-03 | MRNA | Moderna, Inc. | M — Option exercise | 2.5K | — | |
| 2026-05-29 | MRNA | Moderna, Inc. | F — Tax withholding / forfeiture | 159 | $47.61 | $8K |
| 2026-05-29 | MRNA | Moderna, Inc. | M — Option exercise | 328 | — | |
| 2026-05-29 | MRNA | Moderna, Inc. | F — Tax withholding / forfeiture | 374 | $47.03 | $18K |
| 2026-05-29 | MRNA | Moderna, Inc. | M — Option exercise | 773 | — | |
| 2026-04-06 | MRNA | Moderna, Inc. | F — Tax withholding / forfeiture | 703 | $50.03 | $35K |
| 2026-04-06 | MRNA | Moderna, Inc. | M — Option exercise | 1.5K | — | |
| 2026-03-06 | MRNA | Moderna, Inc. | F — Tax withholding / forfeiture | 5.7K | $57.80 | $330K |
| 2026-03-06 | MRNA | Moderna, Inc. | M — Option exercise | 11.8K | — | |
| 2026-03-03 | MRNA | Moderna, Inc. | F — Tax withholding / forfeiture | 4.8K | $51.71 | $248K |
| 2026-03-03 | MRNA | Moderna, Inc. | M — Option exercise | 9.9K | — | |
| 2026-03-03 | MRNA | Moderna, Inc. | F — Tax withholding / forfeiture | 375 | $51.71 | $19K |
| 2026-03-03 | MRNA | Moderna, Inc. | M — Option exercise | 774 | — | |
| 2026-03-03 | MRNA | Moderna, Inc. | F — Tax withholding / forfeiture | 160 | $51.71 | $8K |
| 2026-03-03 | MRNA | Moderna, Inc. | M — Option exercise | 329 | — |
James M. Mock is the Chief Financial Officer of Moderna, Inc., a leading biotech company known for its mRNA technology and COVID-19 vaccine. He has been involved in the financial operations of the company, contributing to its growth and development in the biotech sector.…
4 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($104K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Mock James M profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.